Hurthle cell Carcinoma of Thyroid
💡 The post below is just an outline of the YouTube video and my notes. For the full content, please purchase the notes using the links above.
🧬 Hurthle Cell Carcinoma of Thyroid
📖 Definition of Hurthle Cell Carcinoma of Thyroid
Hurthle Cell Carcinoma is a malignant thyroid tumor composed predominantly of Hurthle cells.
It accounts for 3–10% of all differentiated thyroid cancers.
What are Hurthle cells?
What are some other names of Hurthle cells?
🧠 Historical Background
-
Previously classified as: A variant of follicular carcinoma.
-
Now (WHO classification): Recognized as an independent tumor type due to:
- Distinct molecular alterations
- Different biological behavior
- Unique clinical course
Where does Hurthle Cell Carcinoma of Thyroid originate from?
👩🦳 Epidemiology of Hurthle Cell Carcinoma of Thyroid
-
Age: More common in elderly individuals
-
Sex: Predominantly females
-
Incidence: 3–10% of differentiated thyroid malignancies
🔬 Cytological & Histological Features of Hurthle Cell Carcinoma of Thyroid
🔹 Hurthle Cells — The Characteristic Cell
What is the microscopic appearance of Hurthle cells?
🧫 Microscopy
-
The tumor is usually encapsulated with a thick capsule.
-
Sheets or nests of Hurthle cells with granular cytoplasm are seen.
-
Capsular or vascular invasion must be demonstrated to confirm carcinoma (similar to follicular carcinoma).
📸 Key Diagnostic Point:
The presence of capsular and/or vascular invasion differentiates Hürthle cell carcinoma from Hürthle cell adenoma.
🩺 Clinical Features of Hurthle Cell Carcinoma of Thyroid
Patients usually present with:
-
A thyroid nodule, which can be:
- Solitary or multifocal
- Unilateral or bilateral
-
The swelling is typically firm and non-tender.
-
More aggressive course than follicular carcinoma.
-
Local invasion and recurrence are common.
Metastatic Spread:
-
Hematogenous spread: To lungs, bone, liver
-
Lymphatic spread: More common than in follicular carcinoma
🔍 Investigations of Hurthle Cell Carcinoma of Thyroid
- Fine Needle Aspiration Cytology (FNAC)
- Shows presence of Hurthle cells.
- Cannot differentiate between adenoma and carcinoma — histological evidence of capsular/vascular invasion is essential.
- CT Scan / MRI Neck
- Evaluates local extension and regional lymph nodes.
- Bone Scan
- To detect bony metastases.
🧠 Note: Hurthle cell carcinoma may show reduced iodine uptake on radioisotope scanning.
💊 Treatment of Hurthle Cell Carcinoma of Thyroid
1️⃣ Surgery — Mainstay of Treatment
- Total Thyroidectomy is the treatment of choice.
Why is Total Thyroidectomy the treatment of choice in Hurthle Cell Carcinoma of Thyroid?
2️⃣ Radioiodine Ablation
- Not effective in most cases
Why is radioiodine therapy of limited benefit in Hurthle Cell Carcinoma of Thyroid?
3️⃣ Thyroid Hormone Suppression Therapy
- Lifelong TSH suppression with Levothyroxine is essential
- Prevents stimulation of residual tumor cells.
📉 Prognosis of Hurthle Cell Carcinoma of Thyroid
Hürthle Cell Carcinoma has a worse prognosis compared to follicular carcinoma.
Why does Hurthle Cell Carcinoma of Thyroid have the worst prognosis?
🧾 Summary Table
| Feature | Hürthle Cell Carcinoma |
|---|---|
| Cell of Origin | Follicular epithelial cells |
| Cell Type | Hurthle cells |
| Nature | Malignant tumor |
| Capsular/Vascular invasion | Required for diagnosis |
| Common in | Elderly women |
| Spread | Both hematogenous & lymphatic |
| Radioiodine uptake | Poor |
| Treatment | Total thyroidectomy + lifelong TSH suppression |
| Prognosis | Poorer than follicular carcinoma |
📝 All the topics and questions mentioned in this post are explained in detail in my ENT notes - built for exam success and clinical understanding. Get full access by purchasing the notes.